[SLRX] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
14-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -10.67%
YoY- 6.55%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 0 0 1,269 1,133 105 179 243 -
PBT -5,341 -6,109 -1,852 -2,084 -2,230 -8,223 -8,268 -7.02%
Tax -80 -14 47 -286 0 0 0 -
NP -5,261 -6,095 -1,852 -2,084 -2,230 -8,223 -8,268 -7.25%
Tax Rate - - - - - - - -
Total Cost 5,261 6,095 3,121 3,217 2,335 8,402 8,511 -7.70%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 0.00 0.00 -145.95 -183.95 -2,124.68 -4,604.73 -3,408.99 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -2.20 -3.29 -1.52 -5.46 -77.16 -287.22 -306.27 -56.05%
EPS Diluted -2.20 -3.29 -1.52 -5.46 -77.16 -287.22 -306.27 -56.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.